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Edited by Jesus AvilaAbstract The involvement of caspases in postmitotic cell death
is controversial. Here we report that adult brain and heart are
devoid of many key pro-apoptotic proteins due to a progressive
postnatal silencing event involving a reduction of their transcript
levels. E2F has been shown to control cell cycle progression and
to be transcriptional activator of apoptotic genes. However, our
data demonstrate that apoptotic gene expression in heart, brain
and liver, as well as cardiac and neuronal apoptotic gene silenc-
ing during development, are E2F-independent events. Therefore,
the genes regulating caspase-dependent cell death are expressed
in embryonic organs in an E2F-independent manner and a devel-
opmental-related silencing event represses these genes in postmi-
totic adult tissues.
 2007 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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E2F1. Introduction
Deregulation of the caspase-dependent cell death process
has been involved in the onset and progression of autoimmune
diseases [1,2], and cancer [3,4]. However, despite a considerable
eﬀort directed to untangling the processes implicated in cardiac
and neuronal diseases involving cell loss, the relevance of casp-
ases in these diseases remains debated. Many reports of cyto-
chrome c translocation, nuclear condensation and chromatin
DNA degradation during cardiac and neuronal disease suggest
the involvement of caspases in these situations. However, other
reports have challenged the relevance of caspase activation in
cardiomyocyte and neuron death in these pathologies [5–9].
Changes in the expression of key regulators of the cell death
pathway related to the experimental models used, which in-
clude from cell lines to adult animals, could underlie the diﬀer-
ences in the results.
We previously reported that although embryonic cardiomyo-
cytes express the proteins regulating caspase activation, low lev-
els of these proteins are found in the adult heart, concomitant
with a switch to caspase-independent mechanisms being in-*Corresponding author. Fax: +34 973702213.
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doi:10.1016/j.febslet.2007.11.046volved in ischemia-induced cardiomyocyte damage [9]. Others
have reported low levels of Apaf-1 in cortical neurons [10], ret-
inal neurons [7] and sympathetic neurons [11], as well as low lev-
els of caspase-3 and pro-apoptotic Bcl-2 family members in
retinal neurons [7,8]. However, some reports have shown high
expression of caspases 3 and 9 in neonatal neurons [11], sus-
tained caspase-9 expression in brain [10,12,13] and high expres-
sion of Apaf-1 and some caspases in the heart [13–15].
Therefore, controversy exists about the extent and magnitude
of the changes on apoptotic gene expression in postmitotic cells.
Our aim was to characterize the timing and broadness of the
silencing event aﬀecting the genes regulating the caspase-
dependent death pathway during heart and brain develop-
ment, and to get some clues into the underlying mechanisms.
We show that the development-related silencing of the main
genes involved in the control of caspase-dependent cell death
aﬀect the heart and the brain, and to a lesser extent the liver,
in both rat and mouse. In general, this event initiates after
birth in rodents and culminates during adulthood, with some
genes being expressed only in embryos, such as Caspase-2,
and others, like Bcl-XL, expressed steadily until adulthood.
The apoptotic genes are not re-expressed in vitro in adult
cardiomyocytes during stress situations. Our results also show
that embryonic expression of the caspase-dependent cell death
machinery and its silencing is not inﬂuenced by the transcrip-
tion factor E2F1, despite the fact that E2F1 controls the
expression of some of these genes in other cell types.2. Materials and methods
2.1. Animals, tissues and cells
Sprague–Dawley rats were housed in our Experimental Animal Ser-
vice under standard conditions. Wild-type and mice deﬁcient for E2F1,
E2F2 or both genes were housed and kept at the Animal Facility, Uni-
versity of the Basque Country, as previously reported [16]. Animals
were sacriﬁced in compliance with the guidelines deﬁned by our Insti-
tutional Ethical Committee, which approved the experimental design
of this project. Heart, brain and liver were dissected, minced into small
cubes, rinsed with cold phosphate buﬀered saline and snap-frozen into
liquid nitrogen. Embryonic and adult cardiomyocytes were prepared
and stored as described elsewhere [9]. Other primary cells, tissues
and cell lines were a kind gift from members of our lab.
2.2. Adult ventricular myocyte culture and lentiviral infection
Adult ventricular myocytes were obtained from 9-month-old male
Sprague–Dawley rats and cultured as previously described [9]. Plates

























5782 J. Zhang et al. / FEBS Letters 581 (2007) 5781–578648 h in standard medium as described by others [17] or submitted to
6 h of ischemia (Tyrode’s solution, 0.1% O2 in an InVivo400 hypoxic
chamber, see details in [9]) followed by 18 h of reoxygenation in stan-
dard medium, as described by Kang et al. [18], or left untreated. For
inducing E2F1 expression, the fragment HindIII–EcoRI of the vector
pRc/CMV-HA-E2F1 (kind gift of Erik K Flemington, Dana-Farber
Cancer Institute, Boston, USA), containing the open reading frame
of human E2F1 followed by a hemaglutinin tag (HA) was subcloned
into the PmeI site of the lentiviral overexpression vector pWPI, then
lentivirus particles carrying the empty vector or the E2F1 expression
vector were obtained and added to the cell cultures as described previ-
ously [9] for 72 h. E2F1 expression was monitored by immunodetec-
tion of the HA tag.
2.3. Detection of protein expression
Protein expression was detected in protein extracts diluted in Tris-
buﬀered 2% SDS solution at pH 6.8 as previously reported [9]. Anti-
body data can be found in the Supplementary Table 1. Each immuno-
detection was repeated with two to three diﬀerent membranes
containing samples coming from diﬀerent animals of each age.
2.4. Analysis of the steady-state transcript levels
Total RNA was obtained from frozen tissues with the RNA Spin
Mini kit (GE Healthcare). RNA concentration measurements and ret-
rotranscription were done as described [9]. Equal volumes of cDNA
were ampliﬁed by PCR using a couple of speciﬁc primers expanding
at least two exons within the gene of interest (see Supplementary Table
2 for details) as described elsewhere [9]. Ten microlitre aliquots were
taken at PCR cycles 25, 30 and 35, mixed with SYBR Safe dye (Invit-
rogen) and migrated in a 1% agarose gel. Densitometry of the DNA
bands was performed with the Scion Image software (Scion Corpora-
tion) and qualitative calculations were done comparing data from non-
saturated products (usually, corresponding to PCR cycle 30). Loading
was checked by ampliﬁcation of the unr transcript [9]. Transcript anal-
ysis was performed from three samples of each tissue coming from dif-
ferent animals.Prohibitin
Fig. 1. Detection of proteins involved in apoptosis at diﬀerent
developmental stages in heart, brain and liver. Protein extracts from
cardiac ventricles, brain homogenate and liver were collected from rats
at ages ranging from embryonic day 17 (E17) to 3-month-old adults.
Protein detection was carried out with the antibodies listed in the
Supplementary Table 1. The image is representative of the results
obtained with samples coming from three diﬀerent animals per age. a:
Adaptor proteins; b: caspases; c: Bcl-2 family proteins; d: mitochon-
drial proteins (Cyt c: cytochrome c); and e: structural proteins. CM:
primary isolated rat cardiomyocytes.3. Results
3.1. Expression of the genes implicated in the caspase-dependent
signalling is silenced during postnatal development, notably
in heart and brain
Expression of proteins involved in the control of caspase-
dependent cell death was analyzed in tissues from rats of diﬀer-
ent ages ranging from embryos to adults by using the antibod-
ies described in Supplementary Table 1. Antibodies that have
been checked against knock out mice or knocked down cul-
tured cells were used when possible. Our results show that
the genes involved in the induction of cell death were intensely
repressed in the adult heart and, most of them, also in the
brain. Exceptions were caspase-2, which was only expressed
in embryos, and Bak and Bax, which were downregulated in
all tissues during postnatal development (Fig. 1 and Supple-
mentary Fig. 1). The expression of caspase-9 and executioner
caspases 3 and 7 was reduced in postnatal heart and brain.
We checked the speciﬁcity of caspase-9 antibodies supplied
by Alexis and Cell Signaling comparing the signal obtained
in the same blot for human and rodent cells (Supplementary
Fig. 2). We concluded that caspase-9 expression is reduced in
adult heart and brain when compared to the embryonic stage.
With regard to the expression of anti-apoptotic proteins, Bcl-2
was silenced in heart and brain during development and unde-
tectable in the liver, whereas Bcl-XL was expressed in all tis-
sues until adulthood (Fig. 1).
Decreased expression of the proteins involved in caspase-
dependent cell death has been frequently associated withpost-translational modiﬁcations, involving a reduction of pro-
tein stability [19]. To ascertain whether the developmental
silencing process aﬀected the steady-state amount of the corre-
sponding transcripts, we performed semi-quantitative RT-
PCR in RNA extracts from embryo and adult tissues, as
described in Section 2. Our results demonstrated that expres-
sion silencing aﬀects the amount of mRNA pointing to a
decrease in transcription (Fig. 2).
3.2. E2F1 is neither involved in apoptotic gene expression in the
embryo nor does its development-linked repression aﬀect
apoptotic gene expression in adult tissues
E2F transcription factors are well known by their role in the
control of cell cycle progression. Recently, E2F1 has been sug-
gested to be transcriptional activator of some genes regulating
the caspase activation cascade, such as Apaf-1 [20–23], cas-
pase-8 [24,25], caspase-3 [23,25], caspase-7 [22,23,25], Bid [24]
and Smac [26]. Our results showed that E2F1 expression de-
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Fig. 2. Analysis of the transcript levels for diﬀerent genes involved in apoptosis, in embryonic and adult heart, brain and liver. (a) Total RNA was
extracted from cardiac ventricles, brain homogenate and liver of E17 embryos and 3-month-old rats. RNA was retrotranscribed and the expression of
the genes of interest was measured by PCR as described in Section 2. RT-: PCR product at cycle 35 from a non-retrotranscribed neonatal heart RNA
sample. (b) Bar graphs represent the semi-quantiﬁcation of each speciﬁc gene in arbitrary units (AU), corrected by loading (upstream of n-Ras gene
expression); gray bars: E17 embryo; white bars: 3-month-old adult. For each gene, diﬀerences between embryo and adult expression are shown as
percentage. Values are percent expression change between embryo and adult. nsc: no signiﬁcant change. Graphs are representative of three
experiments made with independent tissue samples.
J. Zhang et al. / FEBS Letters 581 (2007) 5781–5786 5783expression level is proportional to the expression levels of
many apoptotic genes in the embryo, pointing to a role of
E2F in the control of the genes regulating caspase-dependent
death in heart, brain and liver (Fig. 1). However, E2F1 and
E2F2 single and double knockout mice showed no diﬀerences
neither in the embryonic expression of these genes nor in theirrepression during development when compared with their
wild-type littermates (Fig. 3). These data demonstrated that,
although E2F factors can act as transcriptional activators of
key genes regulating the caspase signalling cascade in embry-
onic and tumor cells, they do not control the normal expres-
sion of these genes in heart, brain and liver.
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Fig. 3. Expression of proteins involved in apoptosis in the heart, brain and liver of embryos and adult mice from wild-type and E2F1, E2F2 or
double E2F1-2 knock out strains. Total protein extracts were obtained as described in Section 2 and protein expression was detected by Western blot
using the antibodies listed in the Supplementary Table 1. Images are representative of three independent experiments with comparable results. wt,
wild-type; KO, E2F knockout; DKO, E2F1-2 double knockout. E: E19 embryo; A: P60 adult.
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not re-expressed in cultured adult cardiomyocytes submitted
to stress stimuli
In order to investigate whether the apoptotic machinery can
be re-expressed after a stress input, the expression of apoptotic
genes was analyzed in primary adult ventricular myocytes cul-
tured for 48 h with 1 or 10 nM Angiotensin-II, which has been
reported to induce hypertrophy as well as apoptotic-like DNA
damage and cell death [17], or in cardiomyocytes after 6 h of
ischemia and 18 h of reoxygenation, which induces cell death,
cytochrome c release and apoptotic-like DNA degradation
[18]. The major regulators of the caspase-dependent death
pathway were not re-expressed during these treatments
(Fig. 4). Enhanced E2F1 expression can activate the expression
of genes involved in apoptosis in embryonic ﬁbroblasts and cell
lines [25]. In order to verify whether E2F1 has similar eﬀects in
adult ventricular myocytes, expression of apoptotic genes was
analyzed three days after E2F1 transduction in these cells. De-
spite the increase in E2F1 expression, cardiomyocytes did not
re-express any of the apoptotic genes (Fig. 4). Taken together,
our results suggest that adult cardiac myocytes loss the ability
to express the genes that regulate the caspase-dependent death
pathway and, therefore, cytochrome c release, DNA damage
and phosphatidylserine externalization [17,18] are likely cas-
pase-independent events in these cells.Fig. 4. The expression of the major apoptotic regulators is not
enhanced in adult cardiomyocytes submitted to diﬀerent stress stimuli
reported to induce cell damage. Rat adult ventricular myocytes were
treated with 1 or 10 nM Angiotensin-II (Ang-II) for 48 h, 6 h of
ischemia and 18 h of reoxygenation (I/R), or were induced to
overexpress E2F1 for 72 h (see Section 2). The expression of several
genes involved in the caspase-dependent cell death pathway was
immunodetected after SDS-PAGE in total protein extracts from
control cardiomyocyes (C), cardiomyocytes transduced with empty
vector (B) and stressed cardiomyocytes. Control neonatal cardiac
ﬁbroblasts (CF). The image is representative of three independent
experiments.4. Discussion
Here we report that the proteins controlling caspase-depen-
dent cell death are expressed in the embryonic heart, brain and
liver, but are later silenced during postnatal development,
especially in the heart and the brain. Of note, the expression
of many genes controlling intermediate steps leading to cas-
pase activation is always low in the liver, whose sensitivity to
caspase-dependent cell death could depend on the high expres-
sion of Bid and executioner caspases 3 and 7. The gene silenc-
ing event implies a reduction in the amount of the transcripts
coding for these proteins. Our analysis also demonstrates that
E2F factors are not involved in the expression of the majorregulators of the caspase signalling cascade in the embryo
heart, brain and liver. Finally, the results presented here sug-
gest that postmitotic cardiomyocytes do not re-express the
J. Zhang et al. / FEBS Letters 581 (2007) 5781–5786 5785apoptotic genes neither during stress nor after an increase in
E2F1 expression.
Although previous reports have shown that the expression
of some apoptotic proteins is reduced in postnatal animals
[7–15], simultaneous data argue in favour of high expression
of some of these proteins [10–15]. From our point of view, clar-
ifying this fact has important consequences for the correct
understanding of the mechanisms engaged in cardiomyocyte
and neuron cell death in the adult. Indeed, outstanding re-
search on neurodegenerative and cardiac diseases is being fre-
quently conducted or complemented with studies performed
with embryonic cells and immortalized cell lines, which express
the full caspase-dependent death machinery. Using these mod-
els, caspase activation has been proposed to play a relevant
role in cardiomyocyte and neuron death during disease [27–
29]. However, although the role of caspase-dependent events
on the morphogenesis of the brain and the heart are well estab-
lished [30–32], the role of caspases in postmitotic cell death is
controversial [5–7,33].
Our results show that the pro- death genes in the caspase-
dependent pathway are repressed at both protein and transcript
level during development, in apparent contradiction with previ-
ous reports [14,15]. Although reduction in Apaf-1 expression
and relatively unchanged levels of caspase-9 are observed when
comparing embryos with early neonatal cardiomyocytes [15], in
the present work we show that adult fully diﬀerentiated cardio-
myocytes lack both proteins. A previous work showed that cas-
pase-9 expression increases during heart development [14].
However, the size of the caspase-9 band shown in that report
was smaller than expected and varied in size when comparing
heart and brain extracts. We checked the speciﬁcity of two com-
mercial antibodies against caspase-9. We found that only one
antibody detected correctly the diﬀerent size of the human
and rodent caspase-9 isoforms. This antibody detected cas-
pase-9 only in embryonic and at lesser extent in young heart,
but not in adult heart and adult isolated cardiomyocytes.
Therefore, we conclude that caspase-9 is actually silenced dur-
ing development in heart and brain, alike the rest of caspases
analyzed. Caspase-9 has been suggested to be expressed in adult
mouse heart both at the protein and transcript levels [13]. In
support of the decrease in caspase-9 expression in the myocar-
dium, we report here that isolated adult cardiomyocytes are vir-
tually devoid of caspase-9 (Figs. 1 and 4), suggesting that the
remnant caspase-9 signal in adult heart comes from non-mus-
cular cells. In addition, we have taken into account only non-
saturated signals for our comparative transcript analysis
(Fig. 2), which conﬁrm an important decrease in caspase-9 tran-
script both in the heart and the brain.
If the key regulators of the caspase-dependent cell death
pathway are silenced in postmitotic tissues, the suggested
involvement of caspases in cardiac and neuronal diseases in
the adult (e.g. [28,29,34]) could depend on the re-expression
of the apoptotic signalling cascade in certain pathological con-
ditions. The results presented here suggest that cultured pri-
mary adult cardiomyocytes can not re-express the apoptotic
genes in vitro when submitted to certain death stimuli, although
this does not rule out the re-expression of apoptotic genes
in vivo. In neurons, expression of Apaf-1 has been reported
to be enhanced in a model of brain injury [10] and Caspase-2
up-regulation occurs in certain neurons of a Huntington’s dis-
ease mouse model [29]. However, experiments conducted to
identify the mechanisms involved in neuronal and cardiac celldeath during disease have been performed usually in embryonic
cells. Our results put forward a note of caution on the interpre-
tation of results obtained with embryonic cells or cell lines. We
suggest the need to prove the implication of caspases in adult
cells to conﬁrm the apoptotic gene re-expression event, which
would have important clinical consequences.
Our results also show that expression of apoptosis inducing
factor (AIF), a potentially deleterious protein, is increased in
the adult heart. Interestingly, we and others have demon-
strated that AIF plays actually a beneﬁcial role during reoxy-
genation in cardiomyocytes [35,9], and protects the heart and
the brain against oxidative damage [35,36]. Another interesting
fact is that the expression of pro-death proteins Bax and Bak,
thought to play redundant roles, vary when comparing diﬀer-
ent tissues. While both Bax and Bak are expressed in the young
heart, Bak is the major Bcl-2-related pro-death member in the
brain, whereas Bax is more expressed than Bak in the liver.
These results suggest that the relevance of Bak and Bax in
the control of the mitochondrial events leading to cytochrome
c release is tissue-speciﬁc. Finally, our results show that Bcl-
XL expression is sustained at signiﬁcant levels until adulthood,
suggesting that it could be a crucial protector of mitochondrial
integrity in the adult brain and heart.
Regarding the mechanisms involved in apoptotic gene down-
regulation, our data discard an essential role of E2F1, despite
the fact that this protein has been involved in the expression
of key regulators of the caspase-dependent pathway in prolifer-
ating cells and in the immune system [20–26,37–40]. The lack of
eﬀects on the expression of these genes in E2F1 and 2 double
null mice is unlikely due to compensation by other members
of the E2F1 family because E2F1 has been described to be
the only member able of inducing apoptotic gene expression
[39], and because the ability of other E2F proteins for inducing
apoptosis rely on endogenous E2F1 expression [40].
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